Nls Pharmaceutics Ltd (NLSP) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2023 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nls Pharmaceutics Ltd  (NASDAQ: NLSP)


Nls Pharmaceutics Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nls Pharmaceutics Ltd's ROI in the fourth quarter of 2025?
Nls Pharmaceutics Ltd recorded a cumulative net loss of $-17 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -232.18%.

Within the Healthcare sector 852 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 4663.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 11 7 3 7 -14
Return On Investment (TTM) -232.18 % -1264.59 % 384.33 % 278.59 % -
NLSP's Overall Ranking # 4663 # 0 # # #
Seq. Investment Change TTM 642.8 % - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -17 -12 -12 -12 -12

NLSP Company Profile >> Back to NLSP Roi Comparisons >> See Annual NLSP Return On Investment



Return On Investment NLSP's Ranking
Within: No.
Industry # 405
Sector # 853
Overall # 4663

Return On Investment Statistics
High Average Low
-232.18 %
-288.79 %
-355.41 %
(Dec 31 2025)   (Dec 31 2021)







Financial Statements
Nls Pharmaceutics Ltd's IV. Quarter Investments $ 11 Millions NLSP's Balance sheet
Nls Pharmaceutics Ltd's IV. Quarter Income $ -17 Millions Quarterly NLSP's Income Statement
NLSP's Income by Division See NLSP's Income by Division


NLSP Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 11 -14 -3 3 3
Y / Y Investment Growth - - - -10.38 % -
Net Income in Millions -17 9 -12 -16 -12
Y / Y Net Income Growth - - - - -
Annual Return On Investment -148 % - - -543.03 % -352.43 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NLSP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NLSP's Competitors
Subscribers only: Roi for Nls Pharmaceutics Ltd's Suppliers
Subscribers only: Return On Investment for NLSP's Customers

Other Ratios
NLSP's Roa NLSP's Inventory Turnover Ratio NLSP's Growth Rates NLSP's Dividend Statistics
NLSP's Profitability Ratios NLSP's Asset Turnover Ratio NLSP's Dividend Growth
NLSP's Roe NLSP's Valuation Ratios NLSP's Financial Strength Ratios NLSP's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-07-07T12:13:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.